Management of Right Ventricular ...
The increasing incidence of patients with advanced heart failure, limited donor availability, and continued advancements in the field of mechanical ...
Acute Study of Clinical Effecti ...
Nesiritide, a synthetic drug form of human Btype natriuretic peptide, is approved for the early treatment of dyspnea in acute decompensated heart fa ...
Pathophysiology and Treatment O ...
The anorexia–cachexia syndrome (ACS) occurs in many chronic illnesses, such as cancer, AIDS, and chronic obstructive pulmonary disease in addition t ...
Pulmonary Vasodilation in Acute ...
Pulmonary hypertension in heart failure is associated with exercise intolerance and adverse outcomes. With the availability of multiple drugs that c ...
Diverse Molecular Forms of Plas ...
Recent studies have shown that not only plasma B-type natriuretic peptide (BNP)-32, but also plasma proBNP-108 is increased in heart failure (HF), a ...
Palliative Care and End-of-Life ...
Left ventricular assist devices as destination therapy (DT) improve quality of life for many patients with advanced heart failure. However, DT can b ...
Androgen Deficiency in Heart Fa ...
Androgen deficiency is a hormonal disorder that is frequently observed in advanced chronic conditions. A reduction of androgen blood levels may be c ...
Cardiopulmonary Exercise Test i ...
Patients with cardiovascular diseases commonly present with exercise intolerance, clinically manifest as shortness of breath and fatigue, and these ...
Novel Biomarkers in Acute Heart ...
Heart failure goes beyond mechanical dysfunction and involves an interplay of multiple pathophysiologic mechanisms, including inflammation, tissue r ...
Vitamin D in Chronic Heart Fail ...
Recent evidence suggests a number of mechanisms whereby vitamin D may positively influence the pathophysiology of heart failure. These include actio ...
Soluble Guanylate Cyclase Modul ...
This review summarizes the role of soluble guanylate cyclase (sGC)-cyclic guanosine 3پŒ, 5پŒ-monophosphate pathways in heart failure and several new ...
Functional Adiponectin Resistan ...
The contribution of skeletal muscle myopathy to the phenotype of patients with chronic heart failure (CHF) has become generally accepted. Besides th ...
Immune Modulation in Heart Fail ...
Immune-modulation therapy has had great success in various inflammatory diseases. Despite the promising results of preliminary studies in anti-tumor ...
Therapeutic Use of MicroRNAs in ...
The discovery of regulatory non-coding (nc) RNAs has opened a new world in cell biology. Within this class of ncRNAs, microRNAs (miRNAs) have been f ...
Newer Applications of Nuclear C ...
Radionuclide-based imaging techniques can be applied to the heart failure population to derive clinically useful information. This review discusses ...
Renal Biomarkers of Kidney Inju ...
The cardiorenal syndromes comprise a group of disorders in which impairment of either the heart or the kidney results in injury to the other. Althou ...
Beta-3 Adrenoceptors as New The ...
Catecholamines play a key role in the regulation of cardiovascular function, classically through ک1/2- adrenoreceptors (AR) activation. After ک3-AR ...
Current State of Ventricular As ...
Left ventricular assist device (LVAD) support is an accepted treatment of patients with end-stage heart failure. The increased applicability and exc ...
Recombinant Human Angiotensin-C ...
Angiotensin-converting enzyme 2 (ACE2) is a monocarboxypeptidase that metabolizes several peptides, including the degradation of angiotensin (Ang) I ...
Aldosterone-Receptor Antagonist ...
The recent publication of the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF) has affirmed the importa ...
Specific PI3K Isoform Modulatio ...
Cardiac pathophysiology heavily relies on receptor-mediated signal transduction, and pharmacologic control of such biological processes has proven s ...
New Perspectives in cAMP-Signal ...
Cyclic adenosine 3پŒ,5پŒ-monophosphate (cAMP) mediates the biological effects of various hormones and neurotransmitters. Stimulation of cardiac ƒہ-a ...
Treatment Options for Cheyne-St ...
A national survey in Japan has revealed that about one of five adults in the general population suffers from a sleep problem [1]. However, sleep-dis ...
Carbohydrate Provision in the E ...
Glycemic control in the critically ill patient has remained a controversial issue over the last decade. Several large trials, with widely varying re ...
Appropriate Protein and Specifi ...
Protein utilization and requirements in critical illness are much researched and debated topics. The enhanced turnover and catabolism of protein in ...